Real-time image processing for label-free enrichment of Actinobacteria cultivated in picolitre droplets†
Abstract
The majority of today's antimicrobial therapeutics is derived from
Maintenance work is planned for Tuesday 19th July 2022 from 17:00 to 19:00 (BST).
Members may be unable to log in to access content during this timeframe. If this happens, please wait until after 19:00 (BST) for access to be resumed.
We apologise for any inconvenience this might cause and thank you for your patience.
* Corresponding authors
a
Bio Pilot Plant, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany
E-mail:
martin.roth@hki-jena.de
b
Applied Systems Biology, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany
E-mail:
thilo.figge@hki-jena.de
c German Rheumatism Research Centre (DRFZ), Berlin, Germany
d Nanobiophotonics, Institute of Photonic Technology (IPHT), Jena, Germany
e Friedrich Schiller University, Jena, Germany
The majority of today's antimicrobial therapeutics is derived from
E. Zang, S. Brandes, M. Tovar, K. Martin, F. Mech, P. Horbert, T. Henkel, M. T. Figge and M. Roth, Lab Chip, 2013, 13, 3707 DOI: 10.1039/C3LC50572C
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content